Atlas Trials

Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19

Clinical trial NCT04513561 · COMPLETED

Trial details

NCT number
NCT04513561
Sponsor
University Hospital, Lille
Status
COMPLETED
Study type
OBSERVATIONAL
Inflammatory DiseaseCovid19
Start date
2020-07-21
Primary completion
2020-08-27
Enrollment
921

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.